Analysis of cerebrospinal fluid adenosine deaminase levels in meningitis

Authors

  • Vyankatesh T. Anchinmane Department of Pathology, B.K.L. Walawalkar Rural Medical College, Sawarde, Chiplun, Ratnagiri
  • Shilpa V. Sankhe Department of Pathology, B.K.L. Walawalkar Rural Medical College, Sawarde, Chiplun, Ratnagiri

DOI:

https://doi.org/10.18203/2320-6012.ijrms20162847

Keywords:

Meningitis, Adenosine deaminase, Tuberculous meningitis

Abstract

Background: A precise etiological diagnosis of meningitis is required so that appropriate therapy can be started at the earliest. Due to inconsistent clinical presentations and the lack of a rapid, sensitive and specific test, tuberculous meningitis (TBM) is particularly difficult to diagnose. The present study was done to analyze the utility of adenosine deaminase (ADA) activity in CSF for differentiating TBM from other forms of meningitis.

Methods: In our study, ADA activity measured in 26 TBM, 15 pyogenic meningitis (PM) and 10 aseptic/viral meningitis (AM) cases. A cut-off ADA level of 10 IU/L was used for differentiation of TBM cases from other meningitis cases.

Results: The mean ADA levels in CSF were highest in TBM patients as compared to PM and AM. The sensitivity, specificity and accuracy of ADA were 96.15%, 92% and 94.11% respectively for detection TBM cases from non-tuberculous meningitis cases.

Conclusions: Since ADA test is simple, rapid and inexpensive, it can be used as rapid diagnostic test for differential diagnosis of CSF and confirmation of TBM cases.               

References

Mastroianni CM, Paolotti F, Lichtrer MD, Agostino C, Vullo V, Delia S. Cerebrospinal fluid cytokines in patients with tuberculous meningitis. Clinical Immunopathology. 1997;84:171-6.

Caws M, Wilson SM, Clough C, Drobniewski F. Role of IS6110-targeted PCR, culture, biochemical, clinical, and immunological criteria for diagnosis of tuberculous meningitis. J Clinical Micro. 2000;38(9):3150-5.

Shariff MH, Vidya P. Cerebrospinal fluid adenosine deaminase activity in tuberculous meningitis cases. Search Results. Int J Pharma Bio Sci. 2014;4(1):95-8.

Nethala SV, Anke G. Adenosine deaminase levels in cerebrospinal fluid among tubercular meningitis patients. 2015;3(11):914-8.

Thweites G, Chan TTH, Mai NTH. Tuberculous meningitis. J Neurol Neurosurg Psychait. 2000;68:289-99.

Kennedy DH, Fallon RJ. Tuberculosis meningitis. J Am Med Asso. 1979;241:264-8.

Molavi A, Le FJL. Tuberculous meningitis. Med Clinics North Am. 1985;69:315-31.

Ramakrishna MR, Trupti RR, Shrinivasa Rao K, Shrinivas T, Bhat H. Adenosine deaminase activity in cerebrospinal fluid for diagnosis of tuberculosis meningitis. Int J Pharma Bio Sci. 2013;4(1):344-51.

Martinez VJM, Ocana I, Ribera E. Adenosine deaminase activity in diagnosis of tuberculous peritonitis. Gut. 1986;27:1049-53.

Downloads

Published

2016-12-18

How to Cite

Anchinmane, V. T., & Sankhe, S. V. (2016). Analysis of cerebrospinal fluid adenosine deaminase levels in meningitis. International Journal of Research in Medical Sciences, 4(9), 3855–3857. https://doi.org/10.18203/2320-6012.ijrms20162847

Issue

Section

Original Research Articles